Negative regulation of the IL-1 system by IL-1R2 and IL-1R8: Relevance in pathophysiology and disease

D Supino, L Minute, A Mariancini, F Riva… - Frontiers in …, 2022 - frontiersin.org
Interleukin-1 (IL-1) is a primary cytokine of innate immunity and inflammation. IL-1 belongs to
a complex family including ligands with agonist activity, receptor antagonists, and an anti …

Tuning inflammation and immunity by the negative regulators IL‐1R2 and IL‐1R8

M Molgora, D Supino, A Mantovani… - Immunological …, 2018 - Wiley Online Library
Interleukin‐1 receptor family members (ILR s) and Toll‐Like Receptors (TLR s) are key
players in immunity and inflammation and are tightly regulated at different levels. Most cell …

WikiPathways: building research communities on biological pathways

T Kelder, MP Van Iersel, K Hanspers… - Nucleic acids …, 2012 - academic.oup.com
Here, we describe the development of WikiPathways (http://www. wikipathways. org), a
public wiki for pathway curation, since it was first published in 2008. New features are …

Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammation

Y Zheng, M Humphry, JJ Maguire, MR Bennett… - Immunity, 2013 - cell.com
Necrosis can induce profound inflammation or be clinically silent. However, the mechanisms
underlying such tissue specificity are unknown. Interleukin-1α (IL-1α) is a key danger signal …

Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer

AC Tahira, MS Kubrusly, MF Faria, B Dazzani… - Molecular cancer, 2011 - Springer
Background Pancreatic ductal adenocarcinoma (PDAC) is known by its aggressiveness and
lack of effective therapeutic options. Thus, improvement in current knowledge of molecular …

Negative regulatory receptors of the IL-1 family

C Garlanda, F Riva, E Bonavita, A Mantovani - Seminars in immunology, 2013 - Elsevier
The IL-1 family of ligands and receptors has a central role in both innate and adaptive
immune responses and is tightly controlled by antagonists, decoy receptors, scavengers …

Interleukin-1 receptor type 2 acts with c-Fos to enhance the expression of interleukin-6 and vascular endothelial growth factor A in colon cancer cells and induce …

AC Mar, CH Chu, HJ Lee, CW Chien, JJ Cheng… - Journal of Biological …, 2015 - ASBMB
Interleukin-1 receptor type 2 (IL1R2) acts as a decoy receptor of exogenous IL-1; however,
its intracellular activity is poorly understood. We previously demonstrated that IL1R2 …

Novel insight into mutational landscape of head and neck squamous cell carcinoma

DA Gaykalova, E Mambo, A Choudhary, J Houghton… - PloS one, 2014 - journals.plos.org
Development of head and neck squamous cell carcinoma (HNSCC) is characterized by
accumulation of mutations in several oncogenes and tumor suppressor genes. We have …

Overexpression of MUC1 induces non-canonical TGF-β signaling in pancreatic ductal adenocarcinoma

M Bose, P Grover, AJ Sanders, R Zhou… - Frontiers in cell and …, 2022 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal human cancers.
Transforming Growth Factor Beta (TGF-β) is a cytokine that switches from a tumor …

Decoys and regulatory “receptors” of the IL-1/Toll-like receptor superfamily

C Garlanda, F Riva, E Bonavita, S Gentile… - Frontiers in …, 2013 - frontiersin.org
Members of the IL-1 family play a key role in innate and adaptive immunity and in the
pathogenesis of diverse diseases. Members of IL-1R like receptor (ILR) family include …